Learn more about whether IDEAYA Biosciences, Inc. or Arcus Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Learn more about whether IDEAYA Biosciences, Inc. or Legend Biotech Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
AppLovin (APP) is a strong buy: $605 target after Q4 beat and dip. APP is positioned as a resilient discovery platform, ...
Nexla, the enterprise-grade AI-powered data integration platform for agents, today announced a strategic partnership with Vespa.ai, the creator of the leading AI search platform for building and ...
AI that generates human interaction not hype AI for the sake of AI can end up adding layers between people and the help ...
GSK’s own proprietary platform is called Cogito Forge. It is not a standard AI search model, but one that uses ‘agents’ that ...
Q2 2026 Earnings Call February 18, 2026 6:00 PM ESTCompany ParticipantsGraham Chipchase - CEO & Executive DirectorJoaquin Gil ...
In Lucknow, Uttar Pradesh, chikankari reveals itself only when seen closely—fine, delicate stitches that appear effortless ...
Spirent Luma uses a multi-agent architecture and deterministic rule sets to automate root cause analysis in multi-technology network environments.
Earlier this week, UK advertising trade body the IPA released its latest Agency Census, with yet more evidence of widespread ...
AI Impact explores AI parallels, retail personalization, health care execution, governance and leadership shifts.
How record transaction volumes, PropTech adoption, and digital assets are reshaping Dubai’s real estate market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results